|

Thoracic Tumours Register

RECRUITINGSponsored by Spanish Lung Cancer Group
Actively Recruiting
SponsorSpanish Lung Cancer Group
Started2016-07-21
Est. completion2026-12-30
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT02941458

Summary

Observational, multicenter study in patients with lung cancer and other thoracic tumors. The GECP, in its commitment to improve the treatment and prognosis of patients with lung cancer and other thoracic tumors, has marked the individualization of treatment according to the expression of markers predictive of response to chemotherapeutic agents and molecular inhibitors of cell proliferation as one of its primary objectives. This could significantly improve the prognosis of patients with lung cancer, and will lead to a radical change in routine clinical practice. The aim of the register is to explore all data available of all patients treated because of thoracic tumours.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Patients with thoracic disease, treated with an active treatment or not treated (only palliative care)

Exclusion Criteria:

* Patients with other type of tumours

Conditions2

CancerThoracic Tumors

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.